Table 3 Novel reference intervals for serum kappa FLC (mg/L), serum lambda FLC (mg/L), and FLC ratio in individuals with eGFR of 45–59, 30–44, and < 30 mL/min/1.73 m2.
Group | 0.5th percentile | 99.5th percentile | ||
---|---|---|---|---|
Value | 95% CI | Value | 95% CI | |
Kappa (mg/L) | ||||
eGFR 45–59 | 7.8 | 7.6–8.2 | 83.6 | 70.2–96.2 |
eGFR 30–44 | 8.8 | 6.3–10.4 | 103.3 | 86.9–165.1 |
eGFR < 30 | 11.7 | 11.1–17.0 | 265.1 | 133.4–304.2 |
Lambda (mg/L) | ||||
eGFR 45–59 | 7.3 | 6.5–7.6 | 65.1 | 52.6–73.2 |
eGFR 30–44 | 8.2 | 6.9–9.3 | 73.2 | 66.9–93.3 |
eGFR < 30 | 12.6 | 10.2–14.1 | 150.9 | 115.5–173.4 |
FLC ratio | ||||
eGFR 45–59 | 0.46 | 0.41–0.51 | 2.62 | 2.24–6.93 |
eGFR 30–44 | 0.48 | 0.37–0.54 | 3.38 | 2.45–12.3 |
eGFR < 30 | 0.54 | 0.53–0.61 | 3.30 | 2.27–10.9 |